[go: up one dir, main page]

FI934222A7 - Pyridazinocetic acids - Google Patents

Pyridazinocetic acids Download PDF

Info

Publication number
FI934222A7
FI934222A7 FI934222A FI934222A FI934222A7 FI 934222 A7 FI934222 A7 FI 934222A7 FI 934222 A FI934222 A FI 934222A FI 934222 A FI934222 A FI 934222A FI 934222 A7 FI934222 A7 FI 934222A7
Authority
FI
Finland
Prior art keywords
pyridazinocetic
acids
pyridazinocetic acids
Prior art date
Application number
FI934222A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI934222L (en
FI934222A0 (en
Inventor
Banavara Lakshmana Mylari
William James Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI934222A7 publication Critical patent/FI934222A7/en
Publication of FI934222L publication Critical patent/FI934222L/en
Publication of FI934222A0 publication Critical patent/FI934222A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI934222A 1991-03-28 1992-03-09 PYRIDAZINONAETTIKSYROR FI934222A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67691991A 1991-03-28 1991-03-28
PCT/US1992/001603 WO1992017446A2 (en) 1991-03-28 1992-03-09 Pyridazinone acetic acids aldose reductase inhibitors

Publications (3)

Publication Number Publication Date
FI934222A7 true FI934222A7 (en) 1993-09-27
FI934222L FI934222L (en) 1993-09-27
FI934222A0 FI934222A0 (en) 1993-09-27

Family

ID=24716565

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934222A FI934222A0 (en) 1991-03-28 1992-03-09 PYRIDAZINONAETTIKSYROR

Country Status (19)

Country Link
EP (1) EP0582643A1 (en)
JP (1) JPH06500793A (en)
CN (1) CN1065269A (en)
AU (1) AU658887B2 (en)
BR (1) BR9205810A (en)
CA (1) CA2107104A1 (en)
CZ (1) CZ387092A3 (en)
DE (1) DE9290035U1 (en)
FI (1) FI934222A0 (en)
HU (1) HUT67836A (en)
IE (1) IE920979A1 (en)
IL (1) IL101325A0 (en)
MX (1) MX9201414A (en)
NZ (1) NZ242152A (en)
PT (1) PT100301A (en)
TW (1) TW207998B (en)
WO (1) WO1992017446A2 (en)
YU (1) YU30392A (en)
ZA (1) ZA922238B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60204611T2 (en) 2001-02-28 2006-05-11 Pfizer Products Inc., Groton Sulfonyl-pyridazinone derivatives for use as aldose reductase inhibitors
SE0100873D0 (en) * 2001-03-13 2001-03-13 Astrazeneca Ab Method of treatment
DE60202452C5 (en) 2001-03-30 2006-11-23 Pfizer Products Inc., Groton PYRIDAZINONAL DOSE REDUCTASE INHIBITORS
AU761191B2 (en) * 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
US7572910B2 (en) 2003-02-20 2009-08-11 Pfizer, Inc. Pyridazinone aldose reductase inhibitors
CN111617072B (en) * 2019-02-27 2023-06-20 苏州凯祥生物科技有限公司 Hyperuricemia medicine composition and medicine for treating hyperuricemia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0676391B2 (en) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド Process for producing oxophthalazinyl acetic acid having heterocyclic side chain such as benzothiazole
FR2647676A1 (en) * 1989-06-05 1990-12-07 Union Pharma Scient Appl New pyridazinone derivatives, processes for preparing them and medicaments containing them which are useful, in particular, as aldose reductase inhibitors

Also Published As

Publication number Publication date
PT100301A (en) 1993-06-30
WO1992017446A3 (en) 1992-11-26
IL101325A0 (en) 1992-11-15
EP0582643A1 (en) 1994-02-16
IE920979A1 (en) 1992-10-07
CA2107104A1 (en) 1992-09-29
HUT67836A (en) 1995-05-29
CZ387092A3 (en) 1994-02-16
MX9201414A (en) 1992-10-01
CN1065269A (en) 1992-10-14
TW207998B (en) 1993-06-21
NZ242152A (en) 1994-07-26
YU30392A (en) 1994-11-15
ZA922238B (en) 1993-09-27
WO1992017446A2 (en) 1992-10-15
FI934222L (en) 1993-09-27
JPH06500793A (en) 1994-01-27
AU1779692A (en) 1992-11-02
HU9302728D0 (en) 1993-12-28
BR9205810A (en) 1994-06-28
AU658887B2 (en) 1995-05-04
DE9290035U1 (en) 1993-11-18
FI934222A0 (en) 1993-09-27

Similar Documents

Publication Publication Date Title
FI940642L (en) Imidazolyl-alkenoic acids
ATE137279T1 (en) HEADCASE
FI923058L (en) ESTERIFICATION PROCEDURE
FI924570A7 (en) Benzimidazolephosphonoamino acids
ATA131391A (en) REIBRING
DE69133019D1 (en) IMIDAZOLYL-alkene carboxylic acids
BR9204511A (en) COLLECTOR-WINDER
DE59208716D1 (en) LYMPHOIDES CD30-ANTIGEN
DE59207013D1 (en) SPORTSHOE
FI934222A7 (en) Pyridazinocetic acids
ATA39792A (en) MAEHWERK
MX9101098A (en) PIRIDILTIO OR PIRIDILOXI-ALCANOIC ACIDS
NO921529D0 (en) PHARMASOEYTIC CONNECTION
NO921530L (en) PHARMASOEYTIC CONNECTION
FI923797A7 (en) N-substituted aminomethanediphosphonic acids
ATE163916T1 (en) ETHYL-6-FORMYLOXY-4-HEXENOATE
ATA67791A (en) ROLLSKI
ATA9892A (en) FORMSTEIN
NO920022D0 (en) SATURDED HYDROXYLKYLKINOLIC ACIDS
KR930009125U (en) Connection
DK160091D0 (en) MULTILYN CONNECTION
CA68725S (en) FURNITURE-GAME
BR9102019A (en) BRAZBLOC
BR9104416A (en) SUPERCALIBRATION
BR7102423U (en) MIC-LAV

Legal Events

Date Code Title Description
FD Application lapsed